Report
MarketLine Department
EUR 297.75 For Business Accounts Only

Pharmaceuticals in Germany

Pharmaceuticals in Germany

Summary

Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Germany pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The German pharmaceuticals market had total revenues of $71.3bn in 2017, representing a compound annual growth rate (CAGR) of 7.1% between 2013 and 2017.
- Infrastructure support in Germany is strong for both foreign and domestic companies, which has encouraged investment in research and development centres and the construction of new manufacturing plants.
- An aging population should serve to increase spending; however, governments are under pressure to keep a lid on spending, potentially constraining growth in the market.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Germany
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Germany pharmaceuticals market by value in 2017?
- What will be the size of the Germany pharmaceuticals market in 2022?
- What factors are affecting the strength of competition in the Germany pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Germany's pharmaceuticals market?
Provider
MarketLine
MarketLine

MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.

 For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.

 MarketLine’ holistic business intelligence report collection includes:

 Industry Intelligence

‒ Industry Profiles

‒ Market Forecasts

‒ Porter’s Five Forces Analysis

 Company Intelligence

‒ Company Profiles

‒ SWOT Analysis

‒ Financial Deals

 Country and City Intelligence

‒ Country and City Profiles

‒ PEST/PESTLE Analysis

‒ Socio and macro-economic indicators

Analysts
MarketLine Department

Other Reports from MarketLine

ResearchPool Subscriptions

Get the most out of your insights

Get in touch